Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Owlet Inc (NY: OWLT )

5.460 +0.260 (+5.00%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Owlet Inc

< Previous 1 2 3 4 5 6 Next >
Owlet to Report Third Quarter 2024 Financial Results on November 13, 2024
From Owlet, Inc.
Via Business Wire
OWLET INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Owlet, Inc. - OWLT
From Kahn Swick & Foti, LLC
Via Business Wire
Owlet Regains Compliance With NYSE Continued Listing Standards
From Owlet, Inc.
Via Business Wire
New ‘State of Parenting Report’ Spotlights Universal Parental Struggles; Reveals Exhaustion As The Most Common Emotion Parents Feel In A Baby’s First Year
From Owlet, Inc.
Via Business Wire
TechMediaBreaks – Owlet Inc. (NASDAQ: OWLT) Secures $46.6M in Public Offering and Debt Refinancing
Via Investor Brand Network
Owlet Announces Closing of Public Offering and Comprehensive Debt Refinancing for Total Gross Proceeds of up to $46.6 Million
From Owlet, Inc.
Via Business Wire
Owlet Announces Pricing of Public Offering and Comprehensive Debt Refinancing for Total Gross Proceeds of up to $46.6 Million
From Owlet, Inc.
Via Business Wire
Owlet Announces Proposed Public Offering
From Owlet, Inc.
Via Business Wire
OWLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Owlet, Inc. and Encourages Investors to Contact the Firm!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe
From Owlet, Inc.
Via Business Wire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Owlet, Inc. (OWLT) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
OWLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Owlet, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Owlet Announces Strong Second Quarter 2024 Results, Achieves Record-Breaking Amazon Prime Day
From Owlet, Inc.
Via Business Wire
Owlet Launches Global Campaign Highlighting Life-Changing Stories from Parents
From Owlet, Inc.
Via Business Wire
Owlet Announces CFO Transition and Re-Affirms 2024 Financial Goals
From Owlet, Inc.
Via Business Wire
Owlet Expands Global Footprint with Launch of Medically-Certified Dream Sock™ in the UK and Across Europe
From Owlet, Inc.
Via Business Wire
Owlet to Participate in the 8th Annual Cowen Future of the Consumer Conference
From Owlet, Inc.
Via Business Wire
Owlet Announces UK Medical Certification of Dream Sock®
From Owlet, Inc.
Via Business Wire
Owlet Announces Strong First Quarter 2024 Results
From Owlet, Inc.
Via Business Wire
Owlet Announces European Medical Certification of Dream SockⓇ
From Owlet, Inc.
Via Business Wire
Owlet to Participate in Upcoming Investor Conferences
From Owlet, Inc.
Via Business Wire
Owlet to Report First Quarter 2024 Financial Results on May 6, 2024
From Owlet, Inc.
Via Business Wire
Owlet Forges Groundbreaking Partnership with Wheel to Launch Virtual TeleHealth Services Platform
From Owlet, Inc.
Via Business Wire
Owlet Announces Fourth Quarter and Fiscal Year 2023 Results
From Owlet, Inc.
Via Business Wire
Owlet Announces $9 Million Private Placement Financing
From Owlet, Inc.
Via Business Wire
Owlet to Participate in Cowen’s 44th Annual Health Care Conference
From Owlet, Inc.
Via Business Wire
Owlet Announces Strong Preliminary Fourth Quarter 2023 Results and to Report Fourth Quarter 2023 Financial Results on March 7, 2024
From Owlet, Inc.
Via Business Wire
Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices – Dream Sock® and BabySat™
From Owlet, Inc.
Via Business Wire
Owlet Receives FDA De Novo Classification For Infant Dream Sock®, Shares Rise 30%
Via AB Newswire
Exposures Product Safety
Owlet to Participate in BTIG’s Digital Health Forum
From Owlet, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.